In an article published on Newsweek’s website on September 11th, they raise some of the same points about the value of Sanotize’s Enovid NONS nasal spray (also known as VirX) in fighting the COVID-19 pandemic that we have been writing about here for many months.
The proven value of Enovid isn’t the only reason for the growing pressure on the FDA for some new thinking on how to expand the basket of preventative measures against the rampant delta variant that’s claiming thousands of new victims every day. The problem is becoming a major reason for the dramatic fall in the approval rating of the Biden administration. As Newsweek says, “with his job approval rating plunging and the Delta variant of Covid19 still raging, President Biden this evening laid out new directives…to try to get the virus under control.” But everything the government is doing is focused on vaccines. For unknown reasons, they seem to be avoiding approving a supplementary preventative measure that has been proven to work in keeping infections at bay – nasal sprays.
When you read the Newsweek article, you can sense some frustration. Why are the Federal Drug Administration and the Center for Disease Control putting up unnecessary barriers? There’s a body of evidence on the effectiveness of nasal sprays in keeping the virus out of the body before it can infect the lungs. Companies like SaNOtize have proven products that are already helping thousands of people to stay healthy every day.
Five common misbeliefs about COVID-19 and vaccines
Do people let false claims about health issues get in their way? It is quite disturbing to learn that reliable
Read More »